Chronic migraine becomes “refractory” when preventive treatments don’t work to reduce the frequency of episodes. Treatment may include complementary therapies like neuromodulation.

A drug recently approved to prevent migraine may start working right away, according to a study published in the December 23, ...

[92] Onabotulinum toxin-A is approved for headache prophylaxis in adults with chronic migraine and has approximately the same rate of improvement. Side effects of PAM drugs should be reviewed ...

A newly approved drug, atogepant, may start reducing migraines on the very first day of use, according to a study published ...

Chronic migraines need proactive acute treatment. You need to consult healthcare providers for effective pain management ...

There are four phases of a migraine attack, depending on the severity and type of migraine. Prodrome: A few hours to days, ...

Innovations in Clinical Neuroscience: “CGRP inhibitors for migraine.” Cleveland Clinic: “Chronic Migraine,” “NSAIDs (Nonsteroidal Anti-Inflammatory Drugs).” ...

A drug recently approved to prevent migraine may start working right away, according to a study published in the December 23, ...

People with chronic migraine experience at least ... Lipton et al, Early Improvements With Atogepant for the Preventive Treatment of Migraine, Neurology (2024). DOI: 10.1212/WNL.

Proven methods to prevent migraines attacks, from lifestyle changes to dietary adjustments, helping you reduce frequency and severity of headaches.

A drug recently approved to prevent migraine may start working right away, according to a new study. The study looked at the drug atogepant, which is a calcitonin gene-related peptide (CGRP) receptor ...